Publications
Gollahon Lab Publications
2023
Munir, M.T., Halim, S.A., Santos, J.M., Khan, F., Khan, A., Rahman, M.M., Hussain, F., Al-Harrasi, A., Gollahon, L.S. and Rahman, S.M., 2023. A High Dose of Calcitriol Inhibits Glycolysis and M2 Macrophage Polarization in the Tumor Microenvironment by Repressing mTOR Activation: in vitro and Molecular Docking Studies. Cell Physiol Biochem, 57, pp.105-122.
2022
Mubtasim, N., Moustaid-Moussa, N., Gollahon, L.S. (2022). The Complex Biology of the Metastasis-Promoting, Obesity-Induced Tumor Microenvironment in Breast Cancer. Int. J. Mol. Sci. 2022, 23, 2480. https://doi.org/10.3390/ijms23052480
Schuster, C., Wolpert, N., Moustaid-Moussa, N., Gollahon, L.S. (2022). Combinatorial Effects of the Natural Products Arctigenin, Chlorogenic Acid and Cinnamaldehyde Commit Oxidation Assassination on Breast Cancer Cells. Submitted to Antioxidants. Antioxidants, 11,591. https://doi.org/10.3390/antiox11030591
2021
Hazera Binte Sufian, Julianna Maria Santos, Zeina Shreen Khan, Maliha Tabassum Munir, MD
Khurshidul Zahid, Ahmed Al-Harrasi, Lauren S. Gollahon, Fazle Hussain, Shaikh Mizanoor Rahman
(2021). Parthenolide Inhibits Migration and Reverses the EMT Process in Breast Cancer Cells by
Suppressing TGFβ and TWIST1.Research Square. DOI:10.21203/rs.3.rs-706964/v1
Williamson, M., Moustaid-Moussa, N., Gollahon, LS. (2021). The Molecular PasaDoble: The Fast-Paced Dance of Cellular pH Regulation and Its Implications to Disease. Front. Mol. Med. 1:777088.
doi: 10.3389/fmmed.2021.777088
Schuster, C., Moustaid-Moussa, N., Gollahon, L.S. (2021). The Potential of Combinatorial Small Molecules as Effective Breast Cancer Treatments: A Clinical Approach in Recent Developments in Medicine and Medical Research Vol. 15, Chapter 9, pages 84-119. DOI: 10.9734/bpi/rdmmr/v15/1527B
2020
Al-Jawadi A*, Rasha FA*, Ramalingam L, Alhaj S, Moussa H, Gollahon L, Dharmawardhane S, MoustaidMoussa N (2020). Protective Effects of Eicosapentaenoic Acid in Adipocyte-Breast Cancer Cell Cross Talk. The Journal of Nutritional Biochemistry, Volume 75, 108244, (*Co-first author). https://doi.org/10.1016/j.jnutbio.2019.108244
Rasha FA, Ramalingam L, Gollahon L, Rahman RL, Rahman SM, Menikdiwela KR, Moustaid-Moussa N (2019). Mechanisms Linking the Renin-Angiotensin System, Obesity, and Breast Cancer. Endocrine related Cancer, Volume/Issue: Volume 26: Issue 12, Page Range: R653–R672. DOI: https://doi.org/10.1530/ERC-19-0314
Rasha FA, Ramalingam L, Moussa H, Menikdiwela KR, Gollahon L, Rahman RL, Moustaid-Moussa N (2020). Renin-Angiotensin System Inhibition Attenuates Adipocyte-Breast Cancer Cell Interactions. Experimental Cell Reseaerch Volume 394, Issue 1, 1 September 2020, 112114. https://doi.org/10.1016/j.yexcr.2020.112114
Khandelwal S, Boylan M, Kirsch G, Spallholz JE, Gollahon LS (2020). Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer. Antioxidants 9(2), p138. doi:10.3390/antiox9020138
Xu, H., Liu, Q., Casillas, J., Mcanally, M., Mubtasim, N., Gollahon, L.S., Wu, D., Xu, C. (2020). Prediction of cell viability in dynamic optical projection stereolithography-based bioprinting using machine learning. J Intell Manuf. https://doi.org/10.1007/s10845-020-01708-5
Munir, M.T., Ponce, C., Santos, J.M. et al. (2020). VD3 and LXR agonist (T0901317) combination demonstrated greater potency in inhibiting cholesterol accumulation and inducing apoptosis via ABCA1-CHOP-BCL-2 cascade in MCF-7 breast cancer cells. Mol Biol Rep 47, 7771–7782 https://doi.org/10.1007/s11033-020-05854-0
2018
Khandelwal S, Boylan M, Spallholz JE, Gollahon L. (2018). Cytotoxicity of Selenium Immunoconjugates against Triple Negative Breast Cancer Cells. Int J Mol Sci. 2018 Oct 26;19(11). https://doi:10.3390/ijms19113352. PubMed PMID: 30373175; PubMed Central PMCID: PMC6274915.
Munir, M., Ponce, C., Powell, C., Tarafdar, K., Yanagita, T., Choudhury, M., Gollahon, L., and S. Rahman. (2018). The contribution of cholesterol and epigenetic changes to the pathophysiology of breast cancer. Journal of Steroid Biochemistry and Molecular Biology. On-line May 2018. https://doi.org/10.1016/j.jsbmb.2018.05.001
Ahmmed, S.M., Bithi, S.S., Pore, A.A., Mubtasim, N., Schuster, C., Gollahon, L.S., and S.A. Vanapalli (2018). Multi-sample deformability cytometry of cancer cells. APL Bioengineering: Special Issue: Bioengineering in Cancer. 2, 032002; https://doi.org/10.1063/1.5020992
2017
Schuster, C., Mo, H., Shen, C-L., and L.S. Gollahon. (2017). RANK/RANKL/OPG: The axis of breast cancer bone metastasis evil? In press: Journal of Bone and Mineral Metabolism.
Rogowski, M., Gollahon, L., Chellini, G., and F. Assadi-Porter. (2017). Uptake of 3-iodothyronamine hormone analogs by cancer cells inhibit their cell growth and viability. In press: FEBS Open Bio. DOI:10.1002/2211-5463.12205.
D’Costa, B.M., Moustaid-Moussa, N., and L.S. Gollahon. The role of exosomes in breast cancer: What have we learned in ten years? In: Triple-Negative Breast Cancers: Biomarkers, Emerging Therapeutic Strategies and Clinical Challenges. Editor: Marion Montgomery. Nova Science Publishers, Inc. Hauppauge, NY. 2017. Pages 1-61. ISBN:978-1-53612-372-2.
Al-Jawadi, A., Moussa, H., Ramalingam, L., Gollahon, L., Dharmawardhane, S.,Gunaratne, P., Rahman, R., and N. Moustaid-Moussa. Protective properties of n-3 fatty acids and implications in obesity associated cancer. Journal of Nutritional Biochemistry. 53 pp 1-8. DOI: 10.1016/j.jnutbio.2017.09.018
Al-Jawadi, A., Rasha, F., Ramalingam, L., Alhaj, S., Moussa, H., Gollahon, L., Dharmawardhane, S., and N. Moustaid-Moussa. Role of adipocytes on breast cancer cell inflammation, metabolism and migration, and the preventive effects of omega-3 fatty acids. Submitted: International Journal of Molecular Sciences: Manuscript ID: ijms-251253.
2016
Ma, H. and L.S. Gollahon. (2016). Estrogen Receptor Alpha Mediates Estrogen-Induced Expression of Metastasis Suppressor Gene BRMS1. Int. J. Mol. Sci. 2016, 17, 158; doi:10.3390/ijms17020158.
Colomer-Lluch, M., Gollahon, L.S., and R. Serra-Moreno. (2016) Exploiting the Roles of Restriction Factors to Contain HIV Replication and Spread. Current HIV Research, 14(3) pp175-82.
Li, Q., Yang, X., and L.S. Gollahon. (2016) Using Math to Outrun Death (uMOD). In Revision. National Center for Case Study Teaching in Science.
Rogowski, M., Chellini, G., Gollahon, L., and F. Assadi-Porter. 2016. Uptake Of 3-Iodothyronamine Hormone Analogs By Cancer Cells Inhibit Their Cell Growth And Viability. In review. BMC Cancer.
2015
Lee, K. and L.S. Gollahon. (2015). ZSCAN4 and TRF1: A functionally indirect interaction in cancer cells independent of telomerase activity. Biochemical and Biophysical Research Communications (466), 644-649. http://dx.doi.org/10.1016/j.bbrc.2015.09.107. PDF link
2014
Lee, K. and L. S. Gollahon. (2014). Zscan4 Interacts Directly with Human Rap1 in Cancer Cells Regardless of Telomerase Status. Cancer Biology and Therapy Cancer Biology and Therapy 15:8, 1-12: August . Epub: http://dx.doi.org/10.4161/cbt.29220. PDF link
Pan, Z., A. Avila and L. Gollahon. (2014). Paclitaxel Induces Apoptosis in Breast Cancer Cells through Different Calcium—Regulating Mechanisms Depending on External Calcium Conditions. Int. J. Mol. Sci. 2014, 15(2), 2672-2694; doi:10.3390/ijms15022672. PDF link
2013
Avila, A. and L. Gollahon. (2013). A Novel Vista of Cancer, The Umbracesis Hypothesis of Oncogenesis. In review. Medical Hypotheses.
Sotero-Caio, C.G., M. Volleth, L.S. Gollahon, F. Beiyuan, W. Cheng, B. Ng, F. Yang and R.J. Baker. (2013). Chromosomal evolution among leaf-nosed nectarivorous bats - evidence from cross-species chromosome painting, (Phyllostomidae: Chiroptera). BMC Evolutionary Biology, 13:276-288. doi:10.1186/1471-2148-13-276. PDF link
Gollahon, L.S., K. Lee, V. Finckbone, Y. Jeong. (2013). The Natural Product NI-07 Demonstrates Effective Anti-cancer Properties Against NumerousCancer Cell Types. Journal of Solid Tumors. 3(5):30-45. DOI: 10.5430/jst.v3n5p30. PDF link
Lee, J. and L.S. Gollahon. (2013). Mitotic perturbations induced by Nek2 overexpression require interaction with TRF1 in breast cancer cells. CellCycle. 12(23): 1-16. http://dx.doi.org/10.4161/cc.26589 PDF link
Pan, Z. and L. Gollahon. (2013). Paclitaxel attenuates Bcl-2 resistance to apoptosis in breast cancer cells through an endoplasmic reticulum-mediated calcium release in a dosage dependent manner. Biochemical and Biophysical Research Communications. 432(3):431–437. PDF link
Lee, J. and L.S. Gollahon. (2013). Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple‑negative breast cancercells. Int. J. Oncol. 42:839-847. PDF link
2011
Gollahon, L.S., Y. Jeong, V. Finckbone, K. Lee, and J-S. Park. (2011). The Natural Product, NI-07, Is Effective Against Breast Cancer Cells WhileShowing No Cytotoxicity to Normal Cells. The Open Breast Cancer Journal. 3:31- 44. DOI: 10.2174/1876817201103010031 PDF link
2010
Pan Z. and L. Gollahon, (2010). Taxol Directly Induces Endoplasmic Reticulum-Associated Calcium Changes That Promote Apoptosis in BreastCancer Cells. DOI: 10.1111/j.1524-4741.2010.00988.x_2010 Wiley Periodicals, Inc., 1075-122X/10. The Breast Journal. 17(1): 56–70. PDF link
2008
Wankhede S.P., Z. Du, J.M. Berg, M.W. Vaughn, T. Dallas, K.H. Cheng, and L.S. Gollahon. (2008). Cell Detachment Model for an Antibody-BasedMicrofluidic Cancer Screening System. Biotechnol. Prog. 22(5):1426 – 1433. DOI: 10.1021/bp060127d PDF link
2007
Du Z, K.H. Cheng M.W. Vaughn, N.L.Collie and L.S. Gollahon. (2007). Recognition and capture of breast cancer cells using an antibody-basedplatform in a microelectromechanical systems device. Biomed Microdevices. 9(1):35-42. PDF link
2006
Du Z., N. Colls, K.H. Cheng, M.W. Vaughn and L.S. Gollahon. (2006). Microfluidic-based diagnostics for cervical cancer cells. Biosensors andBioelectronics, 21(10):1991 – 1995. PDF link
2004
Berg, J., M. Holtz, Y. Su, R. Bunuan, J. Wilhelm, T. Dallas, R. Gale, L. Gollahon, S. Gangopadhyay and H. Temkin. (2004). Towards IntegratingGraduate Research and Education with Internal Research Internships: Experiences and Assessment. INEER Special Volume, Pages 1 – 11.
2003
Berg J. M., M. Holtz, S. Gangopadhyay, J. Wilhelm, Y.-L. Su, R. Bunuan, L. Gollahon, R. Gale, T. Dallas and H. Temkin, (2003). Towards IntegratingResearch and Education Using ŒInternal Internships,12 Proceedings of the 2003 International Conference on Engineering Education, ICEE-2003,Valencia, Spain.
2002
Elmore, L.W., K.C.Turner, L.S.Gollahon, M.R.Landon, A.Akalin, C.K.Jackson-Cook, and S.E.Holt. (2002). Telomerase protects cancer-prone cellsfrom chromosomal instability and spontaneous immortalization. Cancer Biology and Therapy. 1(4): 391-397. PDF link
2001
Martinez, G.M., L.S. Gollahon, K. Shafer, S.K. Oomman, C. Busch and R. Martinez-Zaguilan. (2001). Fluorescent pH probes, Fluorescent Proteins,and Intrinsic Cellular Fluorochromes are Tools to Study Cytosolic pH (pH cyt) in Mammalian Cells. Proc. Soc. Int. Opt. Engin. SPIE. 4259:144-156, 2001
2000
Gollahon, L.S., and S.E. Holt. (2000). Alternative methods of extracting telomerase activity from human tumor samples. Cancer Lett. 159(2):141-149.
Duarte, X., T. Anderson, M. Grimson, R. Strauss, L.S. Gollahon, M.J. San Francisco. (2000). Erwinia chrysanthemi can kill mammalian cells inculture. FEMS Microbiol. Lett. 190:81-86.
Savre-Train, I., L.S. Gollahon and S.E Holt. (2000). Expression of telomerase activity in immortal and tumor-derived cell lines is regulated bytelomere shortening. Proc. Soc. Exp. Biol. and Med. 223:379-388.